References
- Ramakrishna G, Midthun D E. Churg-Strauss syndrome.Ann Allergy, Asthma, & Immun 2001; 86:603–613.
- Hamilos D L, Christensen J. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.J Allergy Clin Immunol 1991; 88:823–824. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Armentia A, Fernández A, Sánchez P, de la Fuente R, Sanchís E, Méndez J, Parra I, Puyo M. Asthma and vasculitis: response to intravenous immunoglobulins.Allergol Immunopathol 1993; 21:47–52. [CSA]
- Levy Y, George J, Fabbrizzi F, Potman P, Paz Y, Shoenfeld Y. Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins.South Med J 1999; 92:412–414. [PUBMED], [INFOTRIEVE], [CSA]
- Murata K, Araki S. Assessment of autonomic neurotoxicity in occupational and environmental health as determined by ECG R-R interval variability: a review.Am J Ind Med 1996; 30:155–163. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y, Fabbrizzi F, Terryberry J, Peter J, Shoenfeld Y. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.Int Arch Allergy Immunol 1999; 119:231–238. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hughes R AC. Systemic reviews of treatment for inflammatory demyelinating neuropathy.J Anat 2002; 200:331–339. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dalakas M C. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.Neurology 2002; 59(12 suppl 6):13–21. [CSA]
- Newburger J W, Takahashi M, Burns J C, Beiser A S, Chung K J, Duffy C E, Glode M P, Mason W H, Reddy V, Sanders S P. The treatment of Kawasaki syndrome with intravenous gamma globulin.N Engl J Med 1986; 315:341–347. [PUBMED], [INFOTRIEVE], [CSA]
- Drucker N A, Colan S D, Lewis A B, Beiser A S, Wessel D L, Takahashi M, Baker A L, Perez-Atayde A R, Newburger J W. Gammaglobulin treatment of acute myocarditis in the pediatric population.Circulation 1994; 89:252–257. [PUBMED], [INFOTRIEVE], [CSA]
- Noth I, Strek M E, Leff A R. Churg-Strauss syndrome.Lancet 2003; 361:587–594. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schmitt W H, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross W L. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.Arthritis Rheum 1998; 41:445–452. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lanham J G, Elkon K B, Pusey C D, Hughes G R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.Medicine (Baltimore) 1984; 63:65–81. [CSA]
- Jayne D RW, Lockwood C M. Intravenous immunoglobulin as sole therapy for systemic vasculitis.Br J Rheumatol 1996; 35:1150–1153. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jayne D RW, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood C M. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.Q J Med 2000; 93:433–439. [CSA]